Category: Washington Post

With CRISPR gene editing, unique treatments begin to take off for rare diseases

Researchers and patients with rare diseases are excited about recent advancements, but such experiments have their own sets of risks and challenges

CDC plans to let people with weakened immune systems get a booster earlier

That means allowing a fourth Pfizer or Moderna shot at three months instead of five.

CDC to expand wastewater monitoring to help track coronavirus trends

Officials want to expand the system to detect other pathogens and outbreaks of food-borne diseases.

N95, KN95 masks provide best protection against covid, CDC study shows

The study shows that wearing any kind of mask in indoor public places significantly lowers the odds of becoming infected with the coronavirus, with N95 or KN95 masks providing the best protection.

Covid-19 live updates: CDC study says N95, KN95 masks offer best protection; free coronavirus tests begin to arrive by mail

“We’ve seen 60 million households request tests, and tens of millions have received them,” said USPS spokesman David Partenheimer. “This is huge demand, and we’re making incredible progress.”

Medicare to offer free at-home coronavirus tests from pharmacies, starting in the spring

The initiative responds to weeks of criticism from members of Congress and advocacy groups that Medicare was left out of an order issued by President Biden last month requiring private insurers to pay for at-home tests.

Building social capital is critical for strong relationships. ADHD can get in the way.

A lack of social capital can lead to a lack of friends. But there are steps you can take to build social capital.

WHO says Europe entering a ‘cease-fire’ in battle with covid as protection grows

“This period of higher protection should be seen as a cease-fire that could bring us enduring peace,” said Hans Kluge, WHO regional director for Europe.

FDA will rigorously review vaccines for children under 5, surgeon general says

U.S. Surgeon General Vivek H. Murthy said the FDA “will not cut any corners” as it reviews the Pfizer-BioNTech vaccine for young children.

Coronavirus vaccination may soon be available for children younger than 5, prompting elation and questions

News that vaccines for children ages 6 months to 5 years may be available by the end of the month has elicited relief – and questions about the approach the companies are taking for emergency use authorization.